DiabetesSource

Insulet Corporation, the leader in tubing-free insulin pump technology
with its OmniPod® Insulin Management System, announced plans to
release its financial results for the second quarter of 2010 on
Thursday, July 29, 2010 after the close of the financial markets.

Insulet will also host a conference call at 5:00 p.m. Eastern Time on
Thursday, July 29, 2010 to discuss its second quarter 2010 financial
results. During the conference call, material information concerning
the Company, its operations, strategies and prospects may be
discussed.

To listen to the conference call, please dial 866-783-2141 for
domestic callers and 857-350-1600 for international callers. The
passcode is 30884849. A replay of the conference call will be
available two hours after the start of the call through August 5,
2010 by dialing 888-286-8010 (domestic) and 617-801-6888
(international), passcode 87145868. An online archive of the
conference call will also be available by accessing the Investor
Information section of the company's website.

About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to
improving the lives of people with diabetes. The Company's OmniPod
Insulin Management System is a revolutionary, discreet and easy-to-use
insulin infusion system that features two easy-to-use parts with no tubing
and fully-automated cannula insertion. Through the OmniPod System,
Insulet seeks to expand the use of continuous subcutaneous insulin infusion
(CSII) therapy among people with insulin-dependent diabetes. Founded in
2000, Insulet is based in Bedford, MA.